← All Qiagen NV filings

Qiagen NV 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NYSE
QGEN
Qiagen NV
20-F: QIAGEN N.V. Files 20-F Report: Modest Growth Amidst Strategic Shift
QIAGEN N.V. reports modest growth in 2024, driven by recurring revenues and strategic focus on key product pillars, while streamlining operations for future profitability.
NYSE
QGEN
Qiagen NV
20-F: QIAGEN Unveils 2023 Stock Plan and Financial Performance Amidst Market Volatility
QIAGEN introduces its 2023 Stock Plan while navigating a complex market environment, marked by a decline in share price but sustained liquidity and a focus on strategic growth pillars.